Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

NCT06624371 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT06624371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06624371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Recruiting
Start date
March 28, 2025
Completion date
October 31, 2027
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse intrinsic pontine glioma, diffuse midline glioma, h3 k27m-mutant, high-grade glioma, medulloblastoma